Skip to main content
Erschienen in: Quality of Life Research 6/2011

01.08.2011 | Brief Communication

Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada

verfasst von: Daria J. O’Reilly, Feng Xie, Eleanor Pullenayegum, Hertzel C. Gerstein, Janet Greb, Gord K. Blackhouse, Jean-Eric Tarride, Jim Bowen, Ron A. Goeree

Erschienen in: Quality of Life Research | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The goal of this study was to analyze health-related quality of life (HRQL) data from a Canadian population with type 2 diabetes in order to estimate the disutility associated with experiencing a diabetes-related complication.

Methods

The EQ-5D, a standardized instrument for use as a measure of health outcome, was administered to 1,147 patients in Hamilton, Ontario, with type 2 diabetes. After controlling for age, gender, and duration of diabetes, changes in utility values were estimated by regressing the EQ-5D scores onto binary indicators for the presence of an event. The primary method of analysis was Ordinary Least Squares (OLS) and due to concerns over non-Normality, bootstrap standard errors (SE) were calculated.

Results

The analysis included 1,143 participants. Based on the OLS model, reductions in HRQL were associated with duration of diabetes (−0.0015, SE = 0.0006), experiencing a myocardial infarction (MI) (−0.059, SE = 0.017), amputation (−0.063, SE = 0.059), stroke (−0.046, SE = 0.023), and kidney failure (−0.102, SE = 0.047).

Conclusion

This study estimated the reductions in HRQL associated with several important complications commonly experienced in patients with diabetes. The greatest impacts on HRQL were associated with kidney failure and MI. The utility values calculated here can be used to assess the outcome of interventions that reduce these diabetes-related complications and will have a useful impact on future economic evaluations of diabetes management strategies in Canada.
Literatur
2.
Zurück zum Zitat Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., et al. (1999). Diabetes and cardiovascular disease: A statement for healthcare professionals from the American heart association. Circulation, 100(10), 1134–1146.PubMed Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., et al. (1999). Diabetes and cardiovascular disease: A statement for healthcare professionals from the American heart association. Circulation, 100(10), 1134–1146.PubMed
3.
Zurück zum Zitat Sobel, B. E., & Schneider, D. J. (2005). Cardiovascular complications in diabetes mellitus. Current Opinion in Pharmacology, 5(2), 143–148.PubMedCrossRef Sobel, B. E., & Schneider, D. J. (2005). Cardiovascular complications in diabetes mellitus. Current Opinion in Pharmacology, 5(2), 143–148.PubMedCrossRef
4.
Zurück zum Zitat Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22(4), 340–349.PubMed Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22(4), 340–349.PubMed
5.
Zurück zum Zitat Holmes, J., Mcgill, S., Kind, P., Bottomley, J., Gillam, S., & Murhpy, M. (2000). Health-related quality of life in type 2 diabetes. Value Health, 3(Suppl 1), S47–S51.CrossRef Holmes, J., Mcgill, S., Kind, P., Bottomley, J., Gillam, S., & Murhpy, M. (2000). Health-related quality of life in type 2 diabetes. Value Health, 3(Suppl 1), S47–S51.CrossRef
6.
Zurück zum Zitat Koopmanschap, M. (2002). Coping with type II diabetes: The patient’s perspective. Diabetologia, 45(7), S18–S22.PubMed Koopmanschap, M. (2002). Coping with type II diabetes: The patient’s perspective. Diabetologia, 45(7), S18–S22.PubMed
7.
Zurück zum Zitat Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E., Wolffenbuttel, B. H., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care, 25(3), 458–463.PubMedCrossRef Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E., Wolffenbuttel, B. H., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care, 25(3), 458–463.PubMedCrossRef
8.
Zurück zum Zitat Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.PubMedCrossRef Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410–420.PubMedCrossRef
9.
Zurück zum Zitat MacKeigan, L. D., & Pathak, D. S. (1992). Overview of health-related quality-of-life measures. American Journal of Hospital Pharmacy, 49(9), 2236–2245.PubMed MacKeigan, L. D., & Pathak, D. S. (1992). Overview of health-related quality-of-life measures. American Journal of Hospital Pharmacy, 49(9), 2236–2245.PubMed
10.
Zurück zum Zitat Anderson, R. M., Fitzgerald, J. T., Wisdom, K., Davis, W. K., & Hiss, R. G. (1997). A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care, 20(3), 299–305.PubMedCrossRef Anderson, R. M., Fitzgerald, J. T., Wisdom, K., Davis, W. K., & Hiss, R. G. (1997). A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care, 20(3), 299–305.PubMedCrossRef
11.
Zurück zum Zitat de Visser, C. L., Bilo, H. J., Groenier, K. H., de Visser, W., & Jong Meyboom-de, B. (2002). The influence of cardiovascular disease on quality of life in type 2 diabetics. Quality of Life Research, 11(3), 249–261.PubMedCrossRef de Visser, C. L., Bilo, H. J., Groenier, K. H., de Visser, W., & Jong Meyboom-de, B. (2002). The influence of cardiovascular disease on quality of life in type 2 diabetics. Quality of Life Research, 11(3), 249–261.PubMedCrossRef
12.
Zurück zum Zitat Feeny, D., Barr, R. D., Furlong, W., et al. (1991). Quality of life of the treatment process in pediatric oncology: An approach to measurement. In D. Osaba (Ed.), Effect of cancer on quality of life. Boca Raton, FL: CRC Press. Feeny, D., Barr, R. D., Furlong, W., et al. (1991). Quality of life of the treatment process in pediatric oncology: An approach to measurement. In D. Osaba (Ed.), Effect of cancer on quality of life. Boca Raton, FL: CRC Press.
13.
Zurück zum Zitat Torrance, G. W., Furlong, W., & Feeny, D. (2002). Health utility estimation. Expert Review of Pharmacoeconomics and Outcomes Research, 2(2), 99–108.PubMedCrossRef Torrance, G. W., Furlong, W., & Feeny, D. (2002). Health utility estimation. Expert Review of Pharmacoeconomics and Outcomes Research, 2(2), 99–108.PubMedCrossRef
14.
Zurück zum Zitat Bagust, A., & Beale, S. (2005). Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Economics, 14(3), 217–230.PubMedCrossRef Bagust, A., & Beale, S. (2005). Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Economics, 14(3), 217–230.PubMedCrossRef
15.
Zurück zum Zitat Coffey, J. T., Brandle, M., Zhou, H., Marriott, D., Burke, R., Tabaei, B. P., et al. (2002). Valuing health-related quality of life in diabetes. Diabetes Care, 25(12), 2238–2243.PubMedCrossRef Coffey, J. T., Brandle, M., Zhou, H., Marriott, D., Burke, R., Tabaei, B. P., et al. (2002). Valuing health-related quality of life in diabetes. Diabetes Care, 25(12), 2238–2243.PubMedCrossRef
16.
Zurück zum Zitat The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977–986.CrossRef The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977–986.CrossRef
17.
Zurück zum Zitat Maddigan, S. L., Feeny, D. H., & Johnson, J. A. (2003). A comparison of the health utilities indices mark 2 and mark 3 in type 2 diabetes. Medical Decision Making, 23(6), 489–501.PubMedCrossRef Maddigan, S. L., Feeny, D. H., & Johnson, J. A. (2003). A comparison of the health utilities indices mark 2 and mark 3 in type 2 diabetes. Medical Decision Making, 23(6), 489–501.PubMedCrossRef
18.
Zurück zum Zitat Maddigan, S. L., Feeny, D. H., & Johnson, J. A. (2005). Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian national population health survey. Quality of Life Research, 14(5), 1311–1320.PubMedCrossRef Maddigan, S. L., Feeny, D. H., & Johnson, J. A. (2005). Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian national population health survey. Quality of Life Research, 14(5), 1311–1320.PubMedCrossRef
19.
Zurück zum Zitat Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes, 5, 21.PubMedCrossRef Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes, 5, 21.PubMedCrossRef
21.
Zurück zum Zitat Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
22.
Zurück zum Zitat Grandy, S., & Fox, K. M. (2008). EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD). Health Qual Life Outcomes, 6, 18.PubMedCrossRef Grandy, S., & Fox, K. M. (2008). EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD). Health Qual Life Outcomes, 6, 18.PubMedCrossRef
23.
Zurück zum Zitat National Institute for Clinical Excellence (2004). Guide to the methods of technology appraisal. London: National Institute for Clinical Excellence. National Institute for Clinical Excellence (2004). Guide to the methods of technology appraisal. London: National Institute for Clinical Excellence.
24.
Zurück zum Zitat Wexler, D. J., Grant, R. W., Wittenberg, E., Bosch, J. L., Cagliero, E., Delahanty, L., et al. (2006). Correlates of health-related quality of life in type 2 diabetes. Diabetologia, 49(7), 1489–1497.PubMedCrossRef Wexler, D. J., Grant, R. W., Wittenberg, E., Bosch, J. L., Cagliero, E., Delahanty, L., et al. (2006). Correlates of health-related quality of life in type 2 diabetes. Diabetologia, 49(7), 1489–1497.PubMedCrossRef
25.
Zurück zum Zitat Brown, G. C., Brown, M. M., Sharma, S., Brown, H., Gozum, M., & Denton, P. (2000). Quality of life associated with diabetes mellitus in an adult population. Journal of Diabetes and its Complications, 14(1), 18–24.PubMedCrossRef Brown, G. C., Brown, M. M., Sharma, S., Brown, H., Gozum, M., & Denton, P. (2000). Quality of life associated with diabetes mellitus in an adult population. Journal of Diabetes and its Complications, 14(1), 18–24.PubMedCrossRef
26.
Zurück zum Zitat Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes Metabolism Research and Reviews, 15(3), 205–218.PubMedCrossRef Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes Metabolism Research and Reviews, 15(3), 205–218.PubMedCrossRef
27.
Zurück zum Zitat Manuel, D. G., & Schultz, S. E. (2004). Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care, 27(2), 407–414.PubMedCrossRef Manuel, D. G., & Schultz, S. E. (2004). Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care, 27(2), 407–414.PubMedCrossRef
28.
Zurück zum Zitat Sharma, S., Oliver-Fernandez, A., Bakal, J., Hollands, H., Brown, G. C., & Brown, M. M. (2003). Utilities associated with diabetic retinopathy: Results from a Canadian sample. British Journal of Ophthalmology, 87(3), 259–261.PubMedCrossRef Sharma, S., Oliver-Fernandez, A., Bakal, J., Hollands, H., Brown, G. C., & Brown, M. M. (2003). Utilities associated with diabetic retinopathy: Results from a Canadian sample. British Journal of Ophthalmology, 87(3), 259–261.PubMedCrossRef
29.
Zurück zum Zitat Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states: are the United States and United Kingdom different? Medical Care, 43(3), 221–228.PubMedCrossRef Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., & Coons, S. J. (2005). Valuations of EQ-5D health states: are the United States and United Kingdom different? Medical Care, 43(3), 221–228.PubMedCrossRef
Metadaten
Titel
Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada
verfasst von
Daria J. O’Reilly
Feng Xie
Eleanor Pullenayegum
Hertzel C. Gerstein
Janet Greb
Gord K. Blackhouse
Jean-Eric Tarride
Jim Bowen
Ron A. Goeree
Publikationsdatum
01.08.2011
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 6/2011
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9828-9

Weitere Artikel der Ausgabe 6/2011

Quality of Life Research 6/2011 Zur Ausgabe